SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): June 22, 2022
COMPASS PATHWAYS PLC
(Exact Name of Registrant as Specified in Its Charter)
England and Wales
(State or Other Jurisdiction of Incorporation)
|England and Wales||001-39522||Not applicable|
|(State or other Jurisdiction of Incorporation)|
33 Broadwick Street
London W1F 0DQ
(Address of Principal Executive Offices; Zip Code)
+1 (646) 905-3974
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|☐||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|☐||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|☐||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|☐||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Securities registered pursuant to Section 12(b) of the Act:
|Title of each class|| |
| ||Name of each exchange on which registered|
|American Depositary Shares, each representing one ordinary share, nominal value £0.008 per share|| ||CMPS|| ||The Nasdaq Global Select Market|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Regulation FD Disclosure.
In December 2021, Freedom to Operate (“FTO”) filed two petitions requesting post grant review of two COMPASS patents (US Patent 10,947,257 and US Patent 10,954,259) before the Patent Trial & Appeal Board of the U.S. Patent and Trademark Office. Each petition challenged the patentability of the claims of each of the COMPASS patents on three main grounds. FTO’s first main ground alleged that the claimed inventions of the COMPASS patents were improperly directed to something that does not exist and thus they were fundamentally flawed and invalid. FTO’s second main ground alleged that the claims of the COMPASS patents were obvious in view of the prior art. FTO’s third main ground alleged that the claims were invalid for lack of enablement.
On June 22, 2022, the Patent Trial & Appeal Board issued decisions in both cases denying institution of post grant review on the merits of the arguments presented in each of the challenges.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|COMPASS PATHWAYS PLC|
|Date: June 24, 2022||By:||/s/ Matthew Owens|
|General Counsel and Chief Legal Officer|